BNP Paribas Exane re-initiated coverage of Sonova (SONVY) with an Underperform rating and CHF 195 price target The firm cites the company’s “weak” end markets and intense competition for the sell rating.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SONVY: